BCL2 and cancer: Alterations in this balance, e.g., by overexpression of anti-apoptotic Bcl-2 family members or loss of expression of pro-apoptotic members, frequently occur in cancers with the consequence that these cancers are rendered resistant to conventional chemo- and radiotherapy (reviewed in Indran et al81).